Active Studies

This study is a long-term study of ataluren in patients with nonsense mutation Duchenne
muscular dystrophy.

Can we detect small thinking impairments in adults with Multiple Sclerosis by measuring their pupil size?


The objective of this study is to determine if it is possible to use non-invasive neurophysiological measurements as potential markers of subtle cognitive impairments in individuals who are at risk for developing and worsening cognitive impairment in Multiple Sclerosis.


The Pulmonary Fibrosis Foundation Patient Registry will collect data on at least 2,000
patients with interstitial lung disease (ILD) at approximately 40 clinical sites in the US.
The Registry is targeting enrollment of approximately 60% of the 2,000 ILD participants to
have idiopathic pulmonary fibrosis (IPF). The aim of the Registry is to create a cohort of
well-characterized patients with interstitial lung disease (ILD) for participation in
retrospective and prospective research

The COMMEND Study will assess the safety and effectiveness of FLX-787 in men and women with
Motor Neuron Disease [including Amyotrophic Lateral Sclerosis (ALS), Primary Lateral
Sclerosis (PLS) or Progressive Muscular Atrophy (PMA)] experiencing muscle cramps.
Participants will be asked to take two study products during the course of the study. One of
these study products will be a placebo.

Approximately 120 participants in approximately 30 study centers across the United States are
expected to take part. Participants will be in the study for approximately 3 months and visit
the study clinic 3 times.

The primary objective of this study is to document lymphedema rates in patients requiring
regional nodal irradiation (RNI) who receive hypofractionated radiation as compared to
conventional radiation.